[Postgastrectomy dumping treated with octreotide (Sandostatin)]
- PMID: 8317033
[Postgastrectomy dumping treated with octreotide (Sandostatin)]
Abstract
Somatostatin and the long acting somatostatin analogue Sandostatin have been shown to be effective in the management of dumping syndrome. We describe a patient with early dumping in whom this management provided total symptomatic relief. The doses was reduced from 50 micrograms to 12.5 micrograms s.c., t.i.d. At this dose clinical and biochemical parameters (blood pressure, pulse rate, packed cell volume, hematocrit, and blood glucose) were found to be within normal levels.
Similar articles
-
Efficacy of depot long-acting release octreotide therapy in severe dumping syndrome.Aliment Pharmacol Ther. 2005 Nov 15;22(10):963-9. doi: 10.1111/j.1365-2036.2005.02681.x. Aliment Pharmacol Ther. 2005. PMID: 16268971 Clinical Trial.
-
Efficacy of the long-acting repeatable formulation of the somatostatin analogue octreotide in postoperative dumping.Clin Gastroenterol Hepatol. 2009 Apr;7(4):432-7. doi: 10.1016/j.cgh.2008.11.025. Epub 2008 Dec 13. Clin Gastroenterol Hepatol. 2009. PMID: 19264574 Clinical Trial.
-
Somatostatin analogue SMS 201-995 (octreotide) as a possible solution to the dumping syndrome after gastrectomy or vagotomy.Br J Surg. 1989 Feb;76(2):140-4. doi: 10.1002/bjs.1800760212. Br J Surg. 1989. PMID: 2702445
-
The place of octreotide in the medical management of the dumping syndrome.Digestion. 1996;57 Suppl 1:114-8. doi: 10.1159/000201413. Digestion. 1996. PMID: 8813487 Review.
-
Octreotide, a long-acting somatostatin analog, in the management of postoperative dumping syndrome. An update.Dig Dis Sci. 1993 Feb;38(2):359-64. doi: 10.1007/BF01307556. Dig Dis Sci. 1993. PMID: 8425449 Review.